Kerntke Otto McGlone Wealth Management Group’s AbbVie ABBV Stock Holding History

Kerntke Otto McGlone Wealth Management Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-7,713	Closed	-$869K	–	38
2021 Q2	$869K	Buy	7,713 +95	+1%	+$10.7K	0.35%	48
2021 Q1	$824K	Sell	7,618 -192	-2%	-$20.5K	0.43%	49
2020 Q4	$837K	Buy	7,810 +120	+2%	+$11.5K	0.49%	48
2020 Q3	$674K	Buy	7,690 +6	+0.1%	+$565	0.49%	51
2020 Q2	$754K	Buy	7,684 +131	+2%	+$11.5K	0.69%	41
2020 Q1	$575K	Buy	7,553 +72	+1%	+$6.13K	0.64%	42
2019 Q4	$662K	Buy	+7,481	New	+$621K	0.56%	51

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Kerntke Otto McGlone Wealth Management Group's ABBV Position: Q3 2021 in Review

Kerntke Otto McGlone Wealth Management Group sold out of AbbVie (ABBV) in Q3 2021, closing a stake of 7,713 shares — an estimated $869K sold.

Kerntke Otto McGlone Wealth Management Group first reported a position in ABBV in Q4 2019 and held it in 7 quarters. The position peaked at $869K in Q2 2021. 2,657 funds tracked by Wall St. Rank hold ABBV as of Q3 2021.

Kerntke Otto McGlone Wealth Management Group reported no remaining AbbVie position as of Q3 2021 after selling out during the quarter.
Kerntke Otto McGlone Wealth Management Group sold 7,713 AbbVie shares in Q3 2021, an estimated $869K.
Kerntke Otto McGlone Wealth Management Group first reported a position in AbbVie in Q4 2019 and held it in 7 quarters.
Kerntke Otto McGlone Wealth Management Group's AbbVie position peaked at $869K in Q2 2021.
2,657 funds tracked by Wall St. Rank held AbbVie as of Q3 2021.

Based on Kerntke Otto McGlone Wealth Management Group's 13F filing for Q3 2021, filed 9 Nov 2021.